Federal Register / Vol. 87, No. 77 / Thursday, April 21, 2022 / Notices 23887 

826 (4th Cir. 2012); Frederick Marsh 

Blanton, M.D., 43 FR 27616, 27617 

(1978). 

This rule derives from the text of two 

provisions of the CSA. First, Congress 

defined the term ‘‘practitioner’’ to mean 

‘‘a physician . . . or other person 

licensed, registered, or otherwise 

permitted, by . . . the jurisdiction in 

which he practices . . . , to distribute, 

dispense, . . . [or] administer . . . a 

controlled substance in the course of 

professional practice.’’ 21 U.S.C. 

802(21). Second, in setting the 

requirements for obtaining a 

practitioner’s registration, Congress 

directed that ‘‘[t]he Attorney General 

shall register practitioners . . . if the 

applicant is authorized to dispense . . . 

controlled substances under the laws of 

the State in which he practices.’’ 21 

U.S.C. 823(f). Because Congress has 

clearly mandated that a practitioner 

possess state authority in order to be 

deemed a practitioner under the CSA, 

the DEA has held repeatedly that 

revocation of a practitioner’s registration 

is the appropriate sanction whenever he 

is no longer authorized to dispense 

controlled substances under the laws of 

the state in which he practices. See, e.g., 

James L. Hooper, 76 FR at 71371–72; 

Sheran Arden Yeates, M.D., 71 FR 

39130, 39131 (2006); Dominick A. Ricci, 

M.D., 58 FR 51104, 51105 (1993); Bobby 

Watts, M.D., 53 FR 11919, 11920 (1988); 

Frederick Marsh Blanton, 43 FR at 

27617. 

According to Ohio law, ‘‘No person 

shall knowingly obtain, possess, or use 

a controlled substance or a controlled 

substance analog,’’ except pursuant to a 

‘‘prescription issued by a licensed 

health professional authorized to 

prescribe drugs if the prescription was 

issued for a legitimate medical 

purpose.’’ Ohio Rev. Code Ann. 

§§ 2925.11(A), (B)(1)(d) (West, current 

through File 85 of the 134th General 

Assembly (2021–2022)). Ohio law 

further states that a ‘‘[l]icensed health 

professional authorized to prescribe 

drugs’’ or ‘‘prescriber’’ means ‘‘an 

individual who is authorized by law to 

prescribe drugs or dangerous drugs or 

drug therapy related devices in the 

course of the individual’s professional 

practice.’’ Id. at § 4729.01(I). The 

definition further provides a limited list 

of authorized prescribers, the relevant 

provision of which is ‘‘[a] physician 

authorized under Chapter 4731[ ] of the 

Revised Code to practice medicine and 

surgery, osteopathic medicine and 

surgery, or podiatric medicine and 

surgery.’’ Id. at § 4729.01(I)(5). 

Additionally, Ohio law permits ‘‘[a] 

licensed health professional authorized 

to prescribe drugs, if acting in the 

course of professional practice, in 

accordance with the laws regulating the 

professional’s practice’’ to prescribe or 

administer schedule II, III, IV, and V 

controlled substances to patients. Id. at 

§ 3719.06(A)(1)(a)–(b). 

Here, the undisputed evidence in the 

record is that Registrant currently lacks 

authority to practice medicine in Ohio. 

As already discussed, a physician is 

authorized by law to prescribe or 

administer drugs in Ohio only when 

authorized to practice medicine and 

surgery under Ohio law. Thus, because 

Registrant lacks authority to practice 

medicine in Ohio and, therefore, is not 

authorized to handle controlled 

substances in Ohio, Registrant is not 

eligible to maintain a DEA registration. 

Accordingly, I will order that 

Registrant’s DEA registration be 

revoked. 

Order 

Pursuant to 28 CFR 0.100(b) and the 

authority vested in me by 21 U.S.C. 

824(a), I hereby revoke DEA Certificate 

of Registration No. AE5735557 issued to 

Larry S. Everhart, M.D. Further, 

pursuant to 28 CFR 0.100(b) and the 

authority vested in me by 21 U.S.C. 

823(f), I hereby deny any pending 

application of Larry S. Everhart, M.D. to 

renew or modify this registration, as 

well as any other pending application of 

Larry S. Everhart, M.D. for additional 

registration in Ohio. This Order is 

effective May 23, 2022. 

Anne Milgram, 

Administrator. 

[FR Doc. 2022–08513 Filed 4–20–22; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1122–0001] 

Agency Information Collection 

Activities; Proposed eCollection 

Requested; Revision of a Currently 

Approved Collection 

AGENCY: Office on Violence Against 

Women, Department of Justice. 

ACTION: 60-Day Notice. 

SUMMARY: The Department of Justice, 

Office on Violence Against Women 

(OVW) will be submitting the following 

information collection request to the 

Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. 

DATES: Comments are encouraged and 

will be accepted for 60 days until June 

21, 2022. 

FOR FURTHER INFORMATION CONTACT: 

Written comments and/or suggestion 

regarding the items contained in this 

notice, especially the estimated public 

burden and associated response time, 

should be directed to Cathy Poston, 

Office on Violence Against Women, at 

202–514–5430 or Catherine.poston@

usdoj.gov. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

(1) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(2) Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(3) Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

(4) Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

(1) Type of Information Collection: 

Revision of a currently approved 

collection. 

(2) Title of the Form/Collection: 

Certification of Compliance with the 

Statutory Eligibility Requirements of the 

Violence Against Women Act as 

Amended. 

(3) Agency form number, if any, and 

the applicable component of the 

Department of Justice sponsoring the 

collection: Form Number: 1122–0001. 

U.S. Department of Justice, Office on 

Violence Against Women. 

(4) Affected public who will be asked 

or required to respond, as well as a brief 

abstract: The affected public includes 

STOP formula grantees (50 states, the 

District of Columbia and five territories 

(Guam, Puerto Rico, American Samoa, 

Virgin Islands, Northern Mariana 

Islands). The STOP Violence Against 

Women Formula Grant Program was 

authorized through the Violence Against 

Women Act of 1994 and reauthorized 

and amended in 2000, 2005, 2013 and 


jspears on DSK121TN23PROD with NOTICES1
23888 Federal Register / Vol. 87, No. 77 / Thursday, April 21, 2022 / Notices 

2022. The purpose of the STOP Formula 

Grant Program is to promote a 

coordinated, multi-disciplinary 

approach to improving the criminal 

justice system’s response to violence 

against women. It envisions a 

partnership among law enforcement, 

prosecution, courts, and victim 

advocacy organizations to enhance 

victim safety and hold offenders 

accountable for their crimes of violence 

against women. The Department of 

Justice’s Office on Violence Against 

Women (OVW) administers the STOP 

Formula Grant Program funds which 

must be distributed by STOP state 

administrators according to statutory 

formula (as amended in 2000, 2005, 

2013, and 2022). 

OVW is submitting this revision to a 

currently approved collection to reflect 

changes made to the statutorily 

mandated certifications for grantees 

under the STOP Formula Grant 

Program. To be eligible for funds, 

applicants must certify that they are in 

compliance with relevant requirements 

under 28 CFR part 90 and 34 U.S.C. 

10441 through 10451. 

The Violence Against Women Act 

Reauthorization Act of 2022, Public Law 

117–103, div. W, 136 Stat. 49, 840–962 

(VAWA 2022), enacted on March 15, 

2022, improves and expands legal tools 

and grant programs addressing domestic 

violence, dating violence, sexual 

assault, and stalking. VAWA 2022 

reauthorized critical grant programs 

created by the original Violence Against 

Women Act and subsequent legislation, 

established new programs, and 

strengthened Federal laws as well as 

adding additional certification 

requirements for the STOP Formula 

Grant Program. 

(5) An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond/reply: It is estimated that it will 

take the approximately 56 respondents 

(state administrators from the STOP 

Formula Grant Program) less than one 

hour to complete a Certification of 

Compliance with the Statutory 

Eligibility Requirements of the Violence 

Against Women Act, as amended. 

(6) An estimate of the total public 

burden (in hours) associated with the 

collection: The total annual hour burden 

to complete the Certification is less than 

56 hours. 

If additional information is required 

contact: Melody Braswell, Deputy 

Clearance Officer, United States 

Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Two Constitution 

Square, 145 N Street NE, 3E, 405B, 

Washington, DC 20530. 

Dated: April 18, 2022. 

Melody Braswell, 

Department Clearance Officer, PRA, U.S. 

Department of Justice. 

[FR Doc. 2022–08529 Filed 4–20–22; 8:45 am] 

BILLING CODE 4410–FX–P 

OFFICE OF MANAGEMENT AND 

BUDGET 

Notice of Listening Sessions and 

Request for Information 

AGENCY: Office of Management and 

Budget. 

ACTION: Notice of listening session(s) 

and request for information. 

SUMMARY: The Build America, Buy 

America Act (‘‘the Act’’), enacted as part 

of the Infrastructure Investment and 

Jobs Act (IIJA) on November 15, 2021, 

provides for the application of domestic 

preference requirements to 

infrastructure projects funded by 

Federal financial assistance and also 

includes requirements to standardize 

and simplify application of the Buy 

American Act in government contracts. 

The Act directs the Office of 

Management and Budget (OMB) to issue 

guidance that will assist agencies as 

they apply the new requirements. OMB 

seeks input from the public concerning 

the Act’s requirement that any 

infrastructure projects funded with 

Federal financial assistance use only 

construction materials ‘‘produced in the 

United States.’’ The Act also requires 

the Federal Acquisition Regulatory 

Council (FAR Council) to provide a 

definition for ‘‘end product 

manufactured in the United States.’’ To 

that end, OMB also seeks input, as a 

member of the FAR Council, on a 

definition for ‘‘end product 

manufactured in the United States,’’ for 

incorporation into the FAR, as required 

by the Act. 

DATES: Written submissions must be 

received on or before 11:59 p.m. May 

23, 2022. 

ADDRESSES: Please submit any written 

comments electronically through the 

Federal eRulemaking Portal at https://

regulations.gov. Go to https://

regulations.gov and select ‘‘Office of 

Management and Budget’’ from the 

agency menu to submit or view public 

comments. 

Please note that all public comments 

received are subject to the Freedom of 

Information Act and will be posted in 

their entirety, including any personal 

and/or business confidential 

information provided. Do not include 

any information you would not like to 

be made publicly available. All 

statements received, including 

attachments and other supporting 

materials, are part of the public record 

and subject to public disclosure. You 

should submit only information that 

you wish to make available publicly. 

In addition to receiving written 

comments, OMB plans to hold two 

public listening sessions, addressing the 

themes specified, on the following 

dates: 

Listening Session 1—April 25 (10:30 

a.m.–12:00 p.m. EDT). This listening 

session will focus on non-ferrous metals 

and plastic and polymer-based products 

(including polyvinylchloride, composite 

building materials, and polymers used 

in fiber optic cables). 

To register for Listening Session 1, 

visit: https://www.eventbrite.com/e/ 

public-listening-session-request-forinformation-on-construction-materialstickets-321722569867. 

Listening Session 2—April 28 (2:00 

p.m.–3:30 p.m. EDT). This listening 

session will focus on glass (including 

optic glass), lumber, drywall, and all 

other products. 

To register for Listening Session 2, 

visit: https://www.eventbrite.com/e/ 

public-listening-session-request-forinformation-on-construction-materialstickets-314863694787. 

FOR FURTHER INFORMATION CONTACT: For 

questions about this RFI, please contact 

Tim Soltis, Office of Management and 

Budget, 202–395–7587, or via email 

(preferred) at Timothy.F.Soltis@

omb.eop.gov. For questions about the 

listening sessions, please email 

MBX.OMB.MadeInAmerica@

omb.eop.gov. 

SUPPLEMENTARY INFORMATION: On 

November 15, 2021, President Biden 

signed into law the Infrastructure 

Investment and Jobs Act, Public Law 

117–58, which includes the Build 

America, Buy America Act (‘‘the Act’’). 

Public Law 117–58, § 70901–52. By 

strengthening requirements for the use 

of iron, steel, manufactured products, 

and construction materials produced in 

the United States, the Act will bolster 

America’s industrial base, protect 

national security, and support highpaying jobs. 

Construction Materials Acquired Under 

Federal Financial Assistance Programs 

The Act affirms, consistent with 

Executive Order 14005, Ensuring the 

Future Is Made in All of America by All 

of America’s Workers (‘‘the Executive 

Order’’), this Administration’s priority 

to ‘‘use terms and conditions of Federal 

financial assistance awards to maximize 

the use of goods, products, and 

materials produced in, and services 


jspears on DSK121TN23PROD with NOTICES1